Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal disease with a 5-year survival rate of less than 10% following diagnosis. The aggressive and invasive properties of pancreatic cancer tumors coupled with poor diagnostic options contribute to the high mortality rate since most patients presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kothari, Aditi, Flick, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152032/
https://www.ncbi.nlm.nih.gov/pubmed/34066284
http://dx.doi.org/10.3390/ijms22105138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152032/
https://www.ncbi.nlm.nih.gov/pubmed/34066284
http://dx.doi.org/10.3390/ijms22105138

Ejemplares similares